MBX Biosciences, Inc. (MBX)
$53.25-2.37%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $2.5B
- Beta
- 0.10
- P/E (TTM)
- -23.72
- Short % float
- 19.95%
- Days to cover
- 11.4
- SI change
- -0.6%
- 1W
- -5.84%
- 1M
- -15.36%
- vs SPY 1W
- -7.39%
- vs SPY 1M
- -17.12%
Industry peers
FMP comparable companies · ranked by market cap
- IOVABUYIovance Biotherapeutics, Inc.$6.4BRECOVERYQ 8$14.23+3.02%
- ERASSELLErasca, Inc.$5.1BRECOVERYQ 4$14.58+9.49%
- AVBPSELLArriVent BioPharma, Inc.$1.3BCRISISQ -5$28.93-1.07%
- REPLSELLReplimune Group, Inc.$1.1BRECOVERYQ 14$13.45-1.21%
- MGTXSELLMeiraGTx Holdings plc$987MCRISISQ 6$10.66-2.96%
- MLTXSELLMoonLake Immunotherapeutics$965MCRISISQ -0$11.47-1.76%
- DNABUYGinkgo Bioworks Holdings, Inc.$817MCRISISQ -17$12.50-1.13%
- ATXSAstria Therapeutics, Inc.$718M$12.58
- VSTMBUYVerastem, Inc.$694MRECOVERYQ 4$7.90-1.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
